ClinicalTrials.gg
CompletedNCT02674477TETATUpdated Aug 22, 2019Results posted

Treatment Engagement With Technology-assisted Treatment

An interventional study of Therapeutic Education System (TES) and Treatment as Usual (TAU) in Alcoholism, Substance-related Disorders and Mentally Ill Chemical Abuse, sponsored by Johns Hopkins University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-22.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
95
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This research is being done to study whether using an Internet-based program, called the Therapeutic Education System (TES), would be helpful for the treatment of substance use and other psychiatric problems.

Read the detailed description

TES has been shown to be helpful as substance abuse treatment in certain groups of people, mainly in the outpatient setting by using interactive modules for education. This study will expose some participants to this program while participants are hospitalized on an inpatient unit, and give the participants access to it after participants are discharged from the hospital. Those participants will still receive treatment as usual, as will the control group.

02

Conditions studied

  • Alcoholism
  • Substance-related Disorders
  • Mentally Ill Chemical Abuse
  • Educational Technology
03

In context

Alcoholism

1,634 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's enrollment of 95 is close to the median of 88 across 1,395 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,809 studies on the registry; 314 are open to participants now.

Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of drug or alcohol problem, plus another psychiatric problem, such as depression or anxiety
  • drug or alcohol use in the last 30 days
  • proficiency in English
  • able to consent to study
  • willing to engage in outpatient treatment
  • willing to allow study team to contact outpatient providers

Exclusion criteria

Exclusion Criteria:

  • psychotic symptoms, such as hearing voices
  • involuntary admission
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
95 participants (actual)

Study arms

  • Experimental
    Therapeutic Education System (TES)

    Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using participant's specific login information. Participants can use it as much or as little as participants like. Participants will continue with treatment as usual during and after hospitalization, as well.

    Device: Therapeutic Education System (TES)

  • Other
    Treatment as Usual (TAU)

    Standard treatment comprises a psychiatrist-led interdisciplinary team as well as face-to-face group counseling for substance use and skills for improving general mental health. There will be no change to the routine care (treatment at usual \[TAU\]) provided to patients on the service.

    Other: Treatment as Usual (TAU)

Interventions

  • DeviceTherapeutic Education System (TES)

    The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.

  • OtherTreatment as Usual (TAU)

    Standard treatment comprises a psychiatrist-led interdisciplinary team as well as face-to-face group counseling for substance use and skills for improving general mental health. There will be no change to the routine care (treatment at usual \[TAU\]) provided to patients on the service.

06

What researchers measure

Primary outcomes

  1. Acceptability of Treatment Based on Survey Questionnaire Completed by Participants

    The acceptability assessment asks about hospital satisfaction for both groups. The questionnaire is a series of questions on Qualtrics on a scale of 0-10. Higher scores signified a more positive response and a better outcome.

    Time frame: prior to discharge from the hospital up to 30 days

Secondary outcomes

  1. Number of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge

    Time frame: 30 days after discharge from the hospital

  2. Number of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge

    Time frame: 30 days after discharge from the hospital

07

Results

Posted Jul 19, 2019

Participant flow

Participant flow — Overall Study
MilestoneTherapeutic Education System (TES)Treatment as Usual (TAU)
Started4847
Completed4045
Not completed82
Withdrew: Protocol violation82

Outcome measures

PrimaryAcceptability of Treatment Based on Survey Questionnaire Completed by Participants

The acceptability assessment asks about hospital satisfaction for both groups. The questionnaire is a series of questions on Qualtrics on a scale of 0-10. Higher scores signified a more positive response and a better outcome.

Time frame:
prior to discharge from the hospital up to 30 days
Reported as:
Mean · score on a scale
Acceptability of Treatment Based on Survey Questionnaire Completed by Participants
score on a scaleTherapeutic Education System (TES)Treatment as Usual (TAU)
Acceptability of Treatment Based on Survey Questionnaire Completed by Participants8.78 ± 0.28.23 ± 0.3
SecondaryNumber of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge
Time frame:
30 days after discharge from the hospital
Reported as:
Count of participants · Participants
Number of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge
ParticipantsTherapeutic Education System (TES)Treatment as Usual (TAU)
Number of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge2319
SecondaryNumber of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge
Time frame:
30 days after discharge from the hospital
Reported as:
Count of participants · Participants
Number of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge
ParticipantsTherapeutic Education System (TES)Treatment as Usual (TAU)
Number of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge1822

Adverse events

Collected over 3 months after discharge from the hospital. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Therapeutic Education System (TES)0/48 (0%)0/48 (0%)0/48 (0%)
Treatment as Usual (TAU)0/47 (0%)0/47 (0%)0/47 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
<=18 years000
Between 18 and 65 years484795
>=65 years000
Age, Continuous
Age, Continuous(years)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
Mean38.5 ± 10.439.8 ± 8.139.01 ± 9.3
Sex: Female, Male
Sex: Female, Male(Participants)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
Female151631
Male333164
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
Hispanic or Latino033
Not Hispanic or Latino484492
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
American Indian or Alaska Native000
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American161834
White322759
More than one race011
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Therapeutic Education System (TES)Treatment as Usual (TAU)Total
United States484795
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Chaple M, Sacks S, McKendrick K, Marsch LA, Belenko S, Leukefeld C, Prendergast M, French M. Feasibility of a computerized intervention for offenders with substance use disorders: a research note. J Exp Criminol. 2014;10(1):105-127. doi: 10.1007/s11292-013-9187-y. PubMed 24634641 ↗
  • Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry. 2014 Jun;171(6):683-90. doi: 10.1176/appi.ajp.2014.13081055. PubMed 24700332 ↗
  • Hammond AS, Antoine DG, Stitzer ML, Strain EC. A Randomized and Controlled Acceptability Trial of an Internet-based Therapy among Inpatients with Co-occurring Substance Use and Other Psychiatric Disorders. J Dual Diagn. 2020 Oct;16(4):447-454. doi: 10.1080/15504263.2020.1794094. Epub 2020 Jul 23. PubMed 32701419 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 14, 2016

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02674477
Responsible party
Sponsor
First posted
Feb 4, 2016
Start date
Feb 29, 2016
Primary completion
Jun 2018
Completion
Sep 2018
Results posted
Jul 19, 2019
Last update
Aug 22, 2019

Study contacts

Eric Strain, MD
principal investigator · Johns Hopkins University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion